Compare BALY & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BALY | VSTM |
|---|---|---|
| Founded | 2004 | 2010 |
| Country | United States | United States |
| Employees | 11700 | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 711.1M | 731.8M |
| IPO Year | 2019 | 2011 |
| Metric | BALY | VSTM |
|---|---|---|
| Price | $13.95 | $8.04 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 10 |
| Target Price | $9.67 | ★ $15.00 |
| AVG Volume (30 Days) | 101.3K | ★ 2.0M |
| Earning Date | 11-09-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 8.37 | ★ 17.49 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,436,189,000.00 | $30,914,000.00 |
| Revenue This Year | $19.05 | $276.56 |
| Revenue Next Year | $8.18 | $55.57 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 209.14 |
| 52 Week Low | $8.44 | $3.43 |
| 52 Week High | $20.74 | $10.82 |
| Indicator | BALY | VSTM |
|---|---|---|
| Relative Strength Index (RSI) | 67.12 | 56.12 |
| Support Level | $12.59 | $7.29 |
| Resistance Level | $14.65 | $8.69 |
| Average True Range (ATR) | 0.88 | 0.51 |
| MACD | 0.19 | -0.02 |
| Stochastic Oscillator | 89.57 | 52.59 |
Ballys Corp is a gaming, hospitality, entertainment, and technology company operating across casino, interactive, and lottery markets. It provides physical and interactive gaming experiences, including casino gaming, iGaming, sportsbook, online bingo, free-to-play games, and technology-driven lottery solutions. The company's segments include Casinos & Resorts, which generates maximum revenue and operates casino and resort properties, a horse racetrack, and a golf course; Bally's Intralot B2B, which provides lottery and technology services; Bally's Intralot B2C, which includes interactive gaming and lottery operations, including a UK casino; and North America Interactive, which includes sports betting and iGaming operations in the United States and Canada.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.